Annual Accounts Payable
$11.15 M
+$3.29 M+41.85%
December 31, 2023
Summary
- As of February 12, 2025, GLUE annual accounts payable is $11.15 million, with the most recent change of +$3.29 million (+41.85%) on December 31, 2023.
- During the last 3 years, GLUE annual accounts payable has risen by +$4.09 million (+57.83%).
- GLUE annual accounts payable is now at all-time high.
Performance
GLUE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.98 M
-$2.50 M-38.54%
September 30, 2024
Summary
- As of February 12, 2025, GLUE quarterly accounts payable is $3.98 million, with the most recent change of -$2.50 million (-38.54%) on September 30, 2024.
- Over the past year, GLUE quarterly accounts payable has dropped by -$2.85 million (-41.74%).
- GLUE quarterly accounts payable is now -64.33% below its all-time high of $11.15 million, reached on December 31, 2023.
Performance
GLUE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GLUE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.9% | -41.7% |
| 3 y3 years | +57.8% | -49.4% |
| 5 y5 years | +249.1% | -49.4% |
GLUE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.0% | -64.3% | at low |
| 5 y | 5-year | at high | +249.1% | -64.3% | +12.7% |
| alltime | all time | at high | +249.1% | -64.3% | +12.7% |
Monte Rosa Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.98 M(-38.5%) |
| Jun 2024 | - | $6.47 M(-5.2%) |
| Mar 2024 | - | $6.83 M(-38.8%) |
| Dec 2023 | $11.15 M(+41.8%) | $11.15 M(+102.8%) |
| Sep 2023 | - | $5.50 M(+3.6%) |
| Jun 2023 | - | $5.31 M(-28.1%) |
| Mar 2023 | - | $7.38 M(-6.1%) |
| Dec 2022 | $7.86 M | $7.86 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $9.75 M(+127.1%) |
| Jun 2022 | - | $4.29 M(-4.8%) |
| Mar 2022 | - | $4.51 M(-31.2%) |
| Dec 2021 | $6.56 M(-7.2%) | $6.56 M(+85.8%) |
| Sep 2021 | - | $3.53 M(-52.7%) |
| Jun 2021 | - | $7.46 M(+1.9%) |
| Mar 2021 | - | $7.33 M(+3.7%) |
| Dec 2020 | $7.07 M(+121.2%) | $7.07 M |
| Dec 2019 | $3.19 M | - |
FAQ
- What is Monte Rosa Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual accounts payable year-on-year change?
- What is Monte Rosa Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly accounts payable year-on-year change?
What is Monte Rosa Therapeutics annual accounts payable?
The current annual accounts payable of GLUE is $11.15 M
What is the all time high annual accounts payable for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual accounts payable is $11.15 M
What is Monte Rosa Therapeutics annual accounts payable year-on-year change?
Over the past year, GLUE annual accounts payable has changed by +$3.29 M (+41.85%)
What is Monte Rosa Therapeutics quarterly accounts payable?
The current quarterly accounts payable of GLUE is $3.98 M
What is the all time high quarterly accounts payable for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly accounts payable is $11.15 M
What is Monte Rosa Therapeutics quarterly accounts payable year-on-year change?
Over the past year, GLUE quarterly accounts payable has changed by -$2.85 M (-41.74%)